Navigation Links
Neogen reports 19% increase in annual revenues
Date:7/22/2014

LANSING, Mich., July 22, 2014 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that revenues for its 2014 fiscal year, which ended May 31, increased 19% from the previous year to $247,405,000. Fiscal year net income was $28,158,000, compared to the prior year's $27,190,000. Adjusted for a 3-for-2 stock split effective Oct. 30, 2013, earnings per share in the current year were $0.76, compared to $0.75 a year ago. Both revenues and net income for the 2014 fiscal year established new all-time highs for the 32-year-old company.

Neogen's fourth quarter revenues were $67,262,000, a 20% increase over revenues from FY 2013's final quarter. Net income in the current fourth quarter was $7,537,000 compared to $7,032,000 in FY 2013, or $0.20 per share compared to $0.19 per share in FY 2013, when adjusted for the stock split.

The fourth quarter was the 89th quarter of the past 94 quarters that Neogen reported revenue increases as compared with the previous year — including all consecutive quarters in the last nine years.

"We are pleased to report another strong year for Neogen, especially in terms of revenue growth, operational strength, and increase in stockholders' equity," said James Herbert, Neogen's chief executive officer and chairman. "Our 23-year record of quarterly growth is a tradition our 900 plus employees are very proud of. Not only was this a good financial year, but we also made three acquisitions and developed a number of new products that will help position us to capitalize on growth opportunities in the markets we serve."

Neogen's gross margin was 49.6% of sales in its 2014 fiscal year, compared to 52.8% of sales for FY 2013. This decrease was due almost entirely to the change in the company's overall product mix. Total operating expenses, expressed as a percentage of total revenues, decreased to 32% in the 2014 fiscal ye
'/>"/>

SOURCE Neogen Corporation
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Neogen COO resigns
2. Neogen licenses Cargill patents
3. Neogen acquires Chem-Tech
4. Neogen reports second quarter results
5. Neogen acquires Prima Tech
6. Neogen shares to be priced Oct. 31
7. Neogen shares begin post-split trading
8. Neogen reports 18% revenue increase
9. Neogen announces 1st quarter results conference call
10. Neogen launches comprehensive dairy heifer genomic test
11. Neogen announces Bohannon retirement, successor named
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... November 21, 2014 2014 Deep ... professional and in-depth research report on the transformer ... definition, classification, application, and industry chain structure as ... international market analysis, including China’s domestic market as ... & economic situation analysis. The report also covers ...
(Date:11/21/2014)... /CNW/ - Aequus Pharmaceuticals Inc. (the "Company" or ... closed a brokered private placement offering (the "Brokered ... Cormark Securities Inc. and Clarus Securities Inc. acted ... a syndicate of agents that also included Wolverton ... "Agents"). Concurrently with the Brokered Offering, the Company ...
(Date:11/21/2014)... , Nov. 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" ... nine month periods ended September 30, 2014.  Biorem,s complete 2014 third ... www.sedar.com ). Financial Summary:Three-months ended September 30, ... per share data) , 2014 , 2013 ... 2,282 , 5,281 , 6,715 , ...
(Date:11/18/2014)... 17, 2014 RPS Diagnostics (RPS®) ... – today announces its third annual partnership of ... Get Smart About Antibiotics Week from November 17-23. ... national campaign designed to highlight the coordinated efforts ... non-profit and for-profit partners to provide education about ...
Breaking Biology Technology:International Transformer Industry - Analysis on Applications, Development & Forecasts Now Available at ReportsnReports.com 2International Transformer Industry - Analysis on Applications, Development & Forecasts Now Available at ReportsnReports.com 3Aequus Pharmaceuticals closes $4.2 million private placement financing 2Aequus Pharmaceuticals closes $4.2 million private placement financing 3Biorem Reports Third Quarter Results 2Biorem Reports Third Quarter Results 3RPS Again Partners with the CDC in Support of the 2014 Get Smart About Antibiotics Week 2RPS Again Partners with the CDC in Support of the 2014 Get Smart About Antibiotics Week 3
... BEIJING, June 2 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE ... of vaccines in China, announced today that,China,s Vice Premier, ... State Council, Ma Kai; Head of General Administration of,Quality ... Health, Chen Zhu; Vice Minister of Ministry of Science ...
... , NEW YORK, June 2 Delcath Systems, Inc. ... testing its proprietary treatment method for primary and metastatic ... States Food and Drug Administration ("FDA") granted Delcath,s application ... treatment of patients with neuroendocrine tumors. , , ...
... MOUNTAIN VIEW, Calif., June 2 VIVUS, Inc. (Nasdaq: ... next-generation therapies to address unmet needs in obesity, diabetes ... be featured in two podium presentations during the 69th ... held from June 5-9, 2009 in New Orleans, Louisiana. ...
Cached Biology Technology:China's Vice Premier, Li Keqiang, Visits Sinovac to Inspect H1N1 Vaccine Production Preparation 2China's Vice Premier, Li Keqiang, Visits Sinovac to Inspect H1N1 Vaccine Production Preparation 3Delcath Systems Granted Third Orphan Drug Designation 2Delcath Systems Granted Third Orphan Drug Designation 3Data on VIVUS' Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting 2Data on VIVUS' Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting 3
(Date:11/4/2014)... amount of death at the right time might actually ... research that could help in understanding animal populations, pest ... a paper in the journal Trends in Ecology ... colleagues conclude that the kind of positive population effect ... or mortality, depends on the size and developmental stage ...
(Date:11/4/2014)... 2014   3D ... Fuel3D , a developer of 3D scanning ... totaling $6.4 million (£4 million). This funding builds on the ... year and paves the way for the commercial launch of ... funding round was led by Chimera Partners and will be ...
(Date:11/3/2014)... published in this month,s Proceedings of the ... a recently discovered communication molecule of the body,s immune ... to limit inflammation and the current study reports its ... ability of the immune system to recognize and target ... effect on the immune system now allows us to ...
Breaking Biology News(10 mins):When less is more: Death in moderation boosts population density in nature 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3PNAS: From HIV to cancer, IL-37 regulates immune system 2
... -- Microbes living at the bottom of the Gulf of ... the Deepwater Horizon oil spill than previously thought, according to ... A paper on that research, conducted before the Deepwater ... a forthcoming issue of the journal Deep-Sea Research II ...
... cells live ever on the verge of suicide, requiring ... prevent the cells from pulling the trigger. This self-destructive ... dangerous precancerous cells are permitted to kill themselves, but ... that store memories, for instance. Rockefeller University scientists are ...
... [Brown University] Living with HIV is difficult under ... virus, alcohol consumption can become particularly perilous in intricate ... the Brown Alcohol Research Center on HIV (ARCH) funded ... Institutes of Health, Brown University scientists will study the ...
Cached Biology News:Microbes may consume far more oil-spill waste than earlier thought 2'Reaper' protein strikes at mitochondria to kill cells 2$7.5M grant to fund research on interaction of drinking and HIV infection 2$7.5M grant to fund research on interaction of drinking and HIV infection 3
Collected from animals that are 16 to 18 months old. Sterile, Cell culture tested, ID clarifier: USA Origin...
... a cytochrome P450 (CYP450) metabolite postulated to ... and cerebral vasculature. In rat cerebral microvessels, ... autoregulatory vasoconstriction. 20-HETE is excreted mainly as ... 20-HETE (20-40 pg/ml in human urine) is ...
... enables you to insert a transposable element ... by in vitro transposition. It uses TnsABC* ... the DNA target. Target DNA may be ... depending on your interests (6-8). If the ...
A set of five peptides which can be used to calibrate a Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) or Electrospray Ionization (ESI) mass spectrometer....
Biology Products: